RANBAXY, WOCKHARDT EYE ALPHARMA

After IT, auto and consumer electronics, it is now time for Big Pharma to turn global predator. The country's largest drug maker Ranbaxy Laboratories Ltd and Habil Khorakiwala-owned Wockhardt Ltd are bidding to acquire a strategic stake in the US-based $1.3 billion Alpharma Inc, sources familiar with the development said. Alpharma is a leading pharma player with a strong portfolio of products in the respiratory, cough and women's health space. While Wockhardt has appointed JP Morgan as the banker, Ranbaxy has chosen JM Morgan Stanley as its advisor to the deal, sources said.

Times of India (http://timesofindia.indiatimes.com/articleshow/1205576.cms)